Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse articles > Author index
Search
Bui Cam Nhung 1 Article
Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries
Eunji Choi, Sangeun Lee, Bui Cam Nhung, Mina Suh, Boyoung Park, Jae Kwan Jun, Kui Son Choi
Epidemiol Health. 2017;39:e2017006.   Published online February 5, 2017
DOI: https://doi.org/10.4178/epih.e2017006
  • 20,458 View
  • 455 Download
  • 89 Web of Science
  • 82 Crossref
AbstractAbstract PDF
Abstract
OBJECTIVES
Assessing long-term success and efficiency is an essential part of evaluating cancer control programs. The mortality-to-incidence ratio (MIR) can serve as an insightful indicator of cancer management outcomes for individual nations. By calculating MIRs for the top five cancers in Organization for Economic Cooperation and Development (OECD) countries, the current study attempted to characterize the outcomes of national cancer management policies according to the health system ranking of each country.
METHODS
The MIRs for the five most burdensome cancers globally (lung, colorectal, prostate, stomach, and breast) were calculated for all 34 OECD countries using 2012 GLOBOCAN incidence and mortality statistics. Health system rankings reported by the World Health Organization in 2000 were updated with relevant information when possible. A linear regression model was created, using MIRs as the dependent variable and health system rankings as the independent variable.
RESULTS
The linear relationships between MIRs and health system rankings for the five cancers were significant, with coefficients of determination ranging from 49 to 75% when outliers were excluded. A clear outlier, Korea reported lower-than-predicted MIRs for stomach and colorectal cancer, reflecting its strong national cancer control policies, especially cancer screening.
CONCLUSIONS
The MIR was found to be a practical measure for evaluating the long-term success of cancer surveillance and the efficacy of cancer control programs, especially cancer screening. Extending the use of MIRs to evaluate other cancers may also prove useful.
Summary

Citations

Citations to this article as recorded by  
  • Global burden of 34 cancers among women in 2020 and projections to 2040: Population‐based data from 185 countries/territories
    Habtamu Mellie Bizuayehu, Abel F. Dadi, Tahir A. Hassen, Daniel Bekele Ketema, Kedir Y. Ahmed, Zemenu Y. Kassa, Erkihun Amsalu, Getiye Dejenu Kibret, Addisu Alehegn Alemu, Animut Alebel, Jemal E. Shifa, Yibeltal Assefa, Gizachew A. Tessema, Peter Sarich,
    International Journal of Cancer.2024; 154(8): 1377.     CrossRef
  • Gastric cancer screening in Western countries: A call to action
    Fabio Farinati, Filippo Pelizzaro
    Digestive and Liver Disease.2024; 56(10): 1653.     CrossRef
  • Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study
    Yehoda M Martei, Lebogang Mokokwe, Ngwao Ngwako, Keaobaka Kebuang, Dipho I Setlhako, Goitsemang Gabaatlhole, Bontswanetse Baaitse, Tumisang Segadimo, Lawrence N Shulman, Frances Barg, Babe E Gaolebale
    BMJ Open.2024; 14(1): e073867.     CrossRef
  • Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis
    Jing Yang, Xin Liu, Qiu-Zi Zhong, Yong Yang, Tao Wu, Si-Ye Chen, Bo Chen, Yong-Wen Song, Hui Fang, Shu-Lian Wang, Yue-Ping Liu, Jing Jin, Ning Li, Ning-Ning Lu, Hao Jing, Yuan Tang, Fan Chen, Xi-Mei Zhang, Wenwen Zhang, Yirui Zhai, Shu-Nan Qi, Ye-Xiong Li
    Cancer Letters.2024; 595: 216793.     CrossRef
  • Utility of auto fluorescence-guided biopsy in suspected lung cancer patients with bronchial mucosal lesions
    Gaozhe Wang, Yan Jin, Kunlong Xiong, Xiaoyan Jin, Linfeng Wang, Chenwei Li
    Photodiagnosis and Photodynamic Therapy.2024; 46: 104057.     CrossRef
  • Policy strategies for capacity building and scale up of the workforce for comprehensive cancer care: a systematic review
    D. Trapani, S.S. Murthy, N. Hammad, R. Casolino, D.C. Moreira, F. Roitberg, J.-Y. Blay, G. Curigliano, A.M. Ilbawi
    ESMO Open.2024; 9(4): 102946.     CrossRef
  • Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15–49 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study
    Zheng Li, Xiaojie Zhang, Chongyuan Sun, Zefeng Li, He Fei, Dongbing Zhao
    International Journal of Surgery.2024; 110(4): 1929.     CrossRef
  • Self-Assembly of Peptides as an Alluring Approach toward Cancer Treatment and Imaging
    Muhammad Hamza Ghafoor, Ben-Li Song, Lei Zhou, Zeng-Ying Qiao, Hao Wang
    ACS Biomaterials Science & Engineering.2024; 10(5): 2841.     CrossRef
  • Cutaneous Melanoma Mortality-to-Incidence Ratio and Its Association With Socioeconomic and Healthcare Factors in Canada: A National Ecological Study
    Santina Conte, Michelle Le, Amina Moustaqim-Barrette, Feras M. Ghazawi, Anastasiya Muntyanu, François Lagacé, Akram Alakel, Elham Rahme, Steven J. Glassman, Ivan V. Litvinov
    Journal of Cutaneous Medicine and Surgery.2024;[Epub]     CrossRef
  • Estimativa de incidência de câncer no Brasil e regiões em 2018: aspectos metodológicos
    Beatriz Cordeiro Jardim, Washington Leite Junger, Regina Paiva Daumas, Gulnar Azevedo e Silva
    Cadernos de Saúde Pública.2024;[Epub]     CrossRef
  • Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics
    Qianru Li, Changfa Xia, He Li, Xinxin Yan, Fan Yang, Mengdi Cao, Shaoli Zhang, Yi Teng, Siyi He, Maomao Cao, Wanqing Chen
    Frontiers of Medicine.2024;[Epub]     CrossRef
  • Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimates
    Habtamu Mellie Bizuayehu, Abel F. Dadi, Kedir Y. Ahmed, Teketo Kassaw Tegegne, Tahir Ahmed Hassen, Getiye Dejenu Kibret, Daniel Bekele Ketema, Meless G. Bore, Subash Thapa, Daniel Bogale Odo, Zemenu Y. Kassa, Desalegn Markos Shifti, Erkihun Amsalu, Peter
    Cancer.2024;[Epub]     CrossRef
  • Global epidemiology of liver cancer 2022: An emphasis on geographic disparities
    Qianru Li, Chao Ding, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Mengdi Cao, Shaoli Zhang, Yi Teng, Nuopei Tan, Jiachen Wang, Changfa Xia, Wanqing Chen
    Chinese Medical Journal.2024; 137(19): 2334.     CrossRef
  • Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020
    Seyed Ehsan Mousavi, Mehran Ilaghi, Yasaman Mirzazadeh, Alireza Mosavi Jarrahi, Seyed Aria Nejadghaderi
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Global, regional, and national trends of dementia incidence and risk factors, 1990–2019: A Global Burden of Disease study
    Abolfazl Avan, Vladimir Hachinski
    Alzheimer's & Dementia.2023; 19(4): 1281.     CrossRef
  • Improved Trends in the Mortality-to-Incidence Ratios for Liver Cancer in Countries with High Development Index and Health Expenditures
    Chang-Cheng Su, Brian-Shiian Chen, Hsin-Hung Chen, Wen-Wei Sung, Chi-Chih Wang, Ming-Chang Tsai
    Healthcare.2023; 11(2): 159.     CrossRef
  • Updated epidemiology of gastrointestinal cancers in East Asia
    Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong
    Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271.     CrossRef
  • Peptide Self-Assembled Nanocarriers for Cancer Drug Delivery
    Vijay Bhooshan Kumar, Busra Ozguney, Anastasia Vlachou, Yu Chen, Ehud Gazit, Phanourios Tamamis
    The Journal of Physical Chemistry B.2023; 127(9): 1857.     CrossRef
  • Stigma and Social Determinants of Health Associated With Fidelity to Guideline-Concordant Therapy in Patients With Breast Cancer Living With and Without HIV in Botswana
    Yehoda M Martei, Modesty Obasohan, Lebogang Mokokwe, Tlotlo Ralefala, Mosepele Mosepele, Robert Gross, Frances K Barg
    The Oncologist.2023; 28(12): e1230.     CrossRef
  • Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
    Joanne Wing Yan Chiu, Soo Chin Lee, James Chung-man Ho, Yeon Hee Park, Ta-Chung Chao, Sung-Bae Kim, Elgene Lim, Ching-Hung Lin, Sherene Loi, Su Ying Low, Lynette Li San Teo, Winnie Yeo, Rebecca Dent
    Drug Safety.2023; 46(10): 927.     CrossRef
  • Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020
    Maedeh Amini, Rajesh Sharma, Chinmay Jani
    Archives of Public Health.2023;[Epub]     CrossRef
  • Unfavorable cancer mortality‐to‐incidence ratios in patients with schizophrenia: A nationwide cohort study in Taiwan, 2000–2019
    Chu‐Syuan Cheng, Wen‐Yin Chen, Hu‐Ming Chang, Chun‐Hung Pan, Sheng‐Siang Su, Shang‐Ying Tsai, Chiao‐Chicy Chen, Chian‐Jue Kuo
    Acta Psychiatrica Scandinavica.2023; 148(4): 347.     CrossRef
  • Mortality‐to‐incidence ratio of early‐onset colorectal cancer in high‐income Asian and Middle Eastern countries: A systemic analysis of the Global Burden of Diseases Study 2019
    Majed Ramadan, Rawiah A. Alsiary, Doaa A. Aboalola
    Cancer Medicine.2023; 12(21): 20604.     CrossRef
  • Spiritual coping strategies: Relationship with physical, anxiety, and depression symptoms of patients with cancer
    Atefeh Ahmadi, Aazam Heidarzadeh, Mahlagha Dehghan, Mohammah Hossein Safarizadeh, Mansooreh Azizzadeh Forouzi
    Indian Journal of Cancer.2023;[Epub]     CrossRef
  • Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019
    Mingjuan Liu, Mengyin Wu, Xintong Liu, Jia Zhou, Yining Lan, Hanlin Zhang, Xinyi zhang, Ling Leng, Heyi Zheng, Jun Li
    Archives of Dermatological Research.2023; 315(10): 2893.     CrossRef
  • The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden
    David Banham, Jonathan Karnon, Alex Brown, David Roder, John Lynch
    Population Health Metrics.2023;[Epub]     CrossRef
  • Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 2019
    Mohammadreza Balooch Hasankhani, Hossein Mirzaei, Ali Karamoozian
    Scientific Reports.2023;[Epub]     CrossRef
  • Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study
    Chinmay T. Jani, Alaaeldin Ahmed, Harpreet Singh, Christian Mouchati, Omar Al Omari, Padmanabh S. Bhatt, Rajesh Sharma, Minaam Farooq, Weitao Liu, Joseph Shalhoub, Dominic Marshall, Justin D. Salciccioli, Jeremy L. Warner, Prudence Lam
    JCO Global Oncology.2023;[Epub]     CrossRef
  • Type 1 diabetes mellitus disease burden in high health expenditure countries between 1990 and 2019
    Michael Edwards, Aurimas Kudzinskas, Andrew Alazawi, Will Hughes, Richard Goodall, Eleanor Harbinson, Justin Salciccioli, Dominic Marshall, Joseph Shalhoub
    Diabetes and Vascular Disease Research.2023;[Epub]     CrossRef
  • Spatial and temporal patterns of prostate cancer burden and their association with Socio‐Demographic Index in Asia, 1990–2019
    Li‐Sha Luo, Jun‐Feng Jiang, Hang‐Hang Luan, Hao Zi, Cong Zhu, Bing‐Hui Li, Xian‐Tao Zeng
    The Prostate.2022; 82(2): 193.     CrossRef
  • Cancer of unknown primary ‐ incidence, mortality trend, and mortality‐to‐incidence ratio is associated with human development index in Central Serbia, 1999–2018: Evidence from the national cancer registry
    Aleksandra Ignjatović, Miodrag Stojanović, Zoran Milošević, Marija Anđelković Apostolović, Tamara Filipović, Nataša Rančić, Roberta Marković, Marija Topalović, Dijana Stojanović, Suzana Otašević
    European Journal of Cancer Care.2022;[Epub]     CrossRef
  • Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990–2019
    Sara Momtazmanesh, Sahar Saeedi Moghaddam, Elaheh Malakan Rad, Sina Azadnajafabad, Narges Ebrahimi, Esmaeil Mohammadi, Mahtab Rouhifard, Negar Rezaei, Masoud Masinaei, Nazila Rezaei, Mohammad Keykhaei, Arya Aminorroaya, Azin Ghamari, Bagher Larijani, Fars
    European Journal of Preventive Cardiology.2022; 29(8): 1287.     CrossRef
  • Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study
    Maedeh Amini, Mehdi Azizmohammad Looha, Elaheh Zarean, Mohamad Amin Pourhoseingholi
    BMC Public Health.2022;[Epub]     CrossRef
  • Mapping Cancer in Africa: A Comprehensive and Comparable Characterization of 34 Cancer Types Using Estimates From GLOBOCAN 2020
    Rajesh Sharma, Aashima, Mehak Nanda, Claudio Fronterre, Paul Sewagudde, Anna E. Ssentongo, Kelsey Yenney, Nina D. Arhin, John Oh, Forster Amponsah-Manu, Paddy Ssentongo
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs
    Freddie Bray, D Maxwell Parkin, Freddy Gnangnon, Gontse Tshisimogo, Jean-Felix Peko, Innocent Adoubi, Mathewos Assefa, Lamin Bojang, Baffour Awuah, Moussa Koulibaly, Nathan Buziba, Anne Korir, Charles Dzamalala, Bakarou Kamate, Shyam Manraj, Josefo Ferro,
    The Lancet Oncology.2022; 23(6): 719.     CrossRef
  • Burden of type 1 diabetes mellitus in the North Africa and Middle East Region, 1990–2019; findings from the global burden of disease study
    Shahnaz Esmaeili, Sahar Saeedi Moghaddam, Nazli Namazi, Fatemeh Bandarian, Zahra Esfahani, Maryam Peimani, Sarvenaz Shahin, Ensieh Nasli-Esfahani, Isa Akbarzadeh, Ali Ghanbari, Negar Rezaei, Nazila Rezaei, Bagher Larijani, Farshad Farzadfar
    Diabetes Research and Clinical Practice.2022; 188: 109912.     CrossRef
  • Cancer incidence and mortality and risk factors in member countries of the " Belt and Road " initiative
    Baohua Wang, Fengdie He, Yanan Hu, Qiutong Wang, Dan Wang, Yuting Sha, Jing Wu
    BMC Cancer.2022;[Epub]     CrossRef
  • Geographical Differences in Kidney Cancer Outcomes of Patients Treated with Immunotherapy: A Systematic Review
    Vinicius Knackfuss Gonçalves, Fernando Sabino Marques Monteiro, Antonia Angeli Gazola, Felipe Pizzolo, Júlia Elisa Hübner, Rodrigo Pellegrini, Alessandra Borba, André P. Fay
    Kidney Cancer.2022; 6(2): 129.     CrossRef
  • Global burden of disease study at the world health organization: research methods for the most comprehensive global study of disease and underlying health policies
    Lee Smith, Jae Il Shin, Soo Young Hwang, Kalthoum Tizaoui, Elena Dragioti, Louis Jacob, Karel Kostev, Seung Won Lee, Ai Koyanagi
    Life Cycle.2022;[Epub]     CrossRef
  • Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990–2019
    Mohsen Abbasi-Kangevari, Naser Ahmadi, Nima Fattahi, Negar Rezaei, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Sahar Saeedi Moghaddam, Sina Azadnajafabad, Zahra Esfahani, Ali-Asghar Kolahi, Shahin Roshani, Sahba Rezazadeh-Khadem, Fateme Gorgani, Seyyed
    PLOS ONE.2022; 17(8): e0271284.     CrossRef
  • A scoping review on population-centered indicators for cancer care continuum
    Vasuki Rajaguru, Jieun Jang, Jeoung A. Kwon, Jae Hyun Kim, Jaeyong Shin, Mison Chun
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • COMPARISON OF TEMPORAL TRENDS IN THE GLOBAL BURDEN OF TRACHEA, BRONCHIAL, AND LUNG CANCER
    İskender ÇETİNTÜRK, Vahit YİĞİT
    Giresun Üniversitesi İktisadi ve İdari Bilimler Dergisi.2022; 8(2): 254.     CrossRef
  • ANALYSIS OF INCIDENCE AND MORTALITY OF GASTROINTESTINAL MALIGNANT TUMORS IN UKRAINE AND WORLDWIDE
    Valeriy Zub
    Acta Medica Leopoliensia.2022; 28(3-4): 22.     CrossRef
  • Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018
    Rajesh Sharma
    Breast Cancer Research and Treatment.2021; 187(2): 557.     CrossRef
  • A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017
    Mohammad Keykhaei, Masood Masinaei, Esmaeil Mohammadi, Sina Azadnajafabad, Negar Rezaei, Sahar Saeedi Moghaddam, Nazila Rezaei, Maryam Nasserinejad, Mohsen Abbasi-Kangevari, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Rosa Haghshenas, Kamyar Koliji, Far
    Experimental Hematology & Oncology.2021;[Epub]     CrossRef
  • The global landscape of drug development of trastuzumab biosimilars
    Dario Trapani, Giuseppe Curigliano
    Journal of Cancer Policy.2021; 28: 100273.     CrossRef
  • Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
    Maedeh Amini, Farid Zayeri, Masoud Salehi
    BMC Public Health.2021;[Epub]     CrossRef
  • Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017
    Sina Azadnajafabad, Sahar Saeedi Moghaddam, Esmaeil Mohammadi, Negar Rezaei, Erfan Ghasemi, Nima Fattahi, Arya Aminorroaya, Reza Azadnajafabad, Armin Aryannejad, Nazila Rezaei, Shohreh Naderimagham, Vahid Haghpanah, Ali H. Mokdad, Hossein Gharib, Farshad
    Cancer Medicine.2021; 10(7): 2496.     CrossRef
  • National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990
    Bahar Ataeinia, Sahar Saeedi Moghaddam, Mahsima Shabani, Kimiya Gohari, Ali Sheidaei, Nazila Rezaei, Shohreh Naderimagham, Erfan Ghasemi, Mahtab Rouhifard Khalilabad, Shahin Roshani, Yosef Farzi, Farshad Farzadfar
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Honey and its protein components: Effects in the cancer immunology
    Ivan Chan‐Zapata, Maira Rubí Segura‐Campos
    Journal of Food Biochemistry.2021;[Epub]     CrossRef
  • A Comparison of the United States and Austrian Healthcare Needs and Systems
    Margaret McAlister, Joey D. Helton
    INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2021;[Epub]     CrossRef
  • Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high‐ and middle‐income Asian countries
    Jasmine Lim, Mizuki Onozawa, Marniza Saad, Teng Aik Ong, Rohan Malek, Hideyuki Akaza
    Cancer Science.2021; 112(6): 2071.     CrossRef
  • A spatial assessment of prostate cancer mortality-to-incidence ratios among South Carolina veterans: 1999–2015
    Peter Georgantopoulos, Jan M. Eberth, Bo Cai, Gowtham Rao, Charles L. Bennett, Christopher T. Emrich, Kathlyn S. Haddock, James R. Hébert
    Annals of Epidemiology.2021; 59: 24.     CrossRef
  • Assessment of quality benchmarks in adenoma detection in Mexico
    Nancy E. Aguilar-Olivos, Ricardo Balanzá, Fernando Rojas-Mendoza, Rodrigo Soto-Solis, Mario A. Ballesteros-Amozurrutia, Norma González-Uribe, Justo A. Fernández-Rivero
    Endoscopy International Open.2021; 09(06): E796.     CrossRef
  • Favorable Lip and Oral Cancer Mortality-to-Incidence Ratios in Countries with High Human Development Index and Expenditures on Health
    Wen-Wei Sung, Yong-Chen Hsu, Chen Dong, Ying-Ching Chen, Yu-Chi Chao, Chih-Jung Chen
    International Journal of Environmental Research and Public Health.2021; 18(11): 6012.     CrossRef
  • In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?
    Jihae An, Young Joong Kim, Jae Young Seo, Cheol Mog Hwang, Dong Hyun Oh, Mu-Sik Lee, Keum Won Kim
    Egyptian Journal of Radiology and Nuclear Medicine.2021;[Epub]     CrossRef
  • Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures
    Tzu-Wei Yang, Chi-Chih Wang, Wei-Cheng Hung, Yu-Hsiang Liu, Wen-Wei Sung, Ming-Chang Tsai
    Frontiers in Public Health.2021;[Epub]     CrossRef
  • Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis
    Tlotlo Ralefala, Lebogang Mokokwe, Swetha Jammalamadugu, Dumelang Legobere, Warona S. Motlhwa, Anthony A. Oyekunle, Surbhi Grover, Frances K. Barg, Lawrence N. Shulman, Yehoda M. Martei
    The Oncologist.2021; 26(12): e2200.     CrossRef
  • Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study
    Máté Várnai, Zoltán Kiss, Rolland Gyulai, Judit Oláh, Péter Holló, Gabriella Emri, András Csejtei, István Kenessey, Angéla Benedek, Zoltán Polányi, Zsófia Nagy-Erdei, Andrea Dániel, Kata Knollmajer, György Rokszin, Ibolya Fábián, Zsófia Barcza, Csaba Polg
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Cancer survival status among male population of Northeast India
    Manoj Kalita, Jagannath Dev Sharma, Debanjana Barman, Nizara Baishya, Chandi Ram Kalita
    Annals of Oncology Research and Therapy.2021; 1(1): 28.     CrossRef
  • Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery
    Rolvix H. Patterson, Victoria G. Fischman, Isaac Wasserman, Jennifer Siu, Mark G. Shrime, Johannes J. Fagan, Wayne Koch, Blake C. Alkire
    Otolaryngology–Head and Neck Surgery.2020; 162(3): 296.     CrossRef
  • Trends of National and Subnational Incidence of Childhood Cancer Groups in Iran: 1990–2016
    Mahsima Shabani, Sahar Saeedi Moghaddam, Bahar Ataeinia, Nazila Rezaei, Farnam Mohebi, Bahram Mohajer, Kimiya Gohari, Ali Sheidaei, Farhad Pishgar, Moein Yoosefi, Farzad Kompani, Farshad Farzadfar
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Evaluation of the Cardiac Protection Conferred by Proanthocyanidins in Grape Seeds against Development of Ehrlich Solid Tumors in Mice
    Maha Abdulrahman Aldubayan
    BioMed Research International.2020; 2020: 1.     CrossRef
  • The economic burden of cancer care for Syrian refugees: a population-based modelling study
    Rima A Abdul-Khalek, Ping Guo, Forbes Sharp, Adrian Gheorghe, Omar Shamieh, Tezer Kutluk, Fouad Fouad, Adam Coutts, Ajay Aggarwal, Deborah Mukherji, Ghassan Abu-Sittah, Kalipso Chalkidou, Richard Sullivan
    The Lancet Oncology.2020; 21(5): 637.     CrossRef
  • Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment
    Heinz Ludwig, Susie Novis Durie, Angela Meckl, Axel Hinke, Brian Durie
    The Oncologist.2020; 25(9): e1406.     CrossRef
  • Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018
    Rajesh Sharma
    Japanese Journal of Clinical Oncology.2020; 50(12): 1370.     CrossRef
  • Evaluating the Effect of Medicaid Expansion on Black/White Breast Cancer Mortality Disparities: A Difference-in-Difference Analysis
    Jason Semprini, Olufunmilayo Olopade
    JCO Global Oncology.2020; (6): 1178.     CrossRef
  • State-Level Disparity in Lung Cancer Survival in the United States
    Yu-Che Lee, Rafael A. Calderon-Candelario, Gregory E. Holt, Michael A. Campos, Mehdi Mirsaeidi
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Inequalities in the burden of female breast cancer in Brazil, 1990–2017
    Maximiliano Ribeiro Guerra, Mário Círio Nogueira, Deborah Carvalho Malta, Camila Soares Lima Côrrea, Maria de Fatima Marinho de Souza, Maria Paula Curado, Mariana Santos Felisbino-Mendes, Meghan Mooney, Mohsen Naghavi, Maria Teresa Bustamante-Teixeira
    Population Health Metrics.2020;[Epub]     CrossRef
  • Disparities in mortality‐to‐incidence ratios by race/ethnicity for female breast cancer in New York City, 2002‐2016
    Tamar B. Nobel, Charles K. Asumeng, John Jasek, Kellie C. Van Beck, Ruchi Mathur, Baozhen Qiao, Jennifer J. Brown
    Cancer Medicine.2020; 9(21): 8226.     CrossRef
  • Enhanced Cancer-targeted Drug Delivery Using Precoated Nanoparticles
    Lu Yu, Mingyu Xu, Wenwen Xu, Wei Xiao, Xue-hua Jiang, Ling Wang, Huile Gao
    Nano Letters.2020; 20(12): 8903.     CrossRef
  • Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application
    Girolamo Ranieri, Mariarita Laforgia, Patrizia Nardulli, Simona Ferraiuolo, Pasquale Molinari, Ilaria Marech, Cosmo Damiano Gadaleta
    Cancers.2019; 11(2): 141.     CrossRef
  • Melanoma prognosis in the United States: Identifying barriers for improved care
    Zachary H. Hopkins, Christopher Moreno, Ryan Carlisle, Aaron M. Secrest
    Journal of the American Academy of Dermatology.2019; 80(5): 1256.     CrossRef
  • The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
    Erik Ladomersky, Denise M. Scholtens, Masha Kocherginsky, Elizabeth A. Hibler, Elizabeth T. Bartom, Sebastian Otto-Meyer, Lijie Zhai, Kristen L. Lauing, Jaehyuk Choi, Jeffrey A. Sosman, Jennifer D. Wu, Bin Zhang, Rimas V. Lukas, Derek A. Wainwright
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival
    Libby Ellis, Aurélien Belot, Bernard Rachet, Michel P. Coleman
    Journal of Global Oncology.2019; (5): 1.     CrossRef
  • National Cancer Mortality-to-Incidence Ratio (MIR) in Iran (2005 - 2014)
    Atieh Akbari, Maryam Khayamzadeh, Reza Salmanian, Ali Ghanbari Motlagh, Gholamreza Roshandel, Maryam Nouri, Mohammad Esmaeil Akbari
    International Journal of Cancer Management.2019;[Epub]     CrossRef
  • The Association between Mortality-to-Incidence Ratios and Health Expenditures in Brain and Nervous System Cancers
    Tsung-Han Lee, Wen-Wei Sung, Lung Chan, Hsiang-Lin Lee, Sung-Lang Chen, Yu-Hui Huang, Aij-Lie Kwan
    International Journal of Environmental Research and Public Health.2019; 16(15): 2739.     CrossRef
  • miR‐181a/b therapy in lung cancer: reality or myth?
    Cornelia Braicu, Diana Gulei, Roxana Cojocneanu, Lajos Raduly, Ancuta Jurj, Erik Knutsen, George Adrian Calin, Ioana Berindan‐Neagoe
    Molecular Oncology.2019; 13(1): 9.     CrossRef
  • Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems
    Dario Trapani, Giuseppe Curigliano, Alexandru Eniu
    Breast Care.2019; 14(6): 373.     CrossRef
  • Epidemiology of prostate cancer in Asian countries
    Takahiro Kimura, Shin Egawa
    International Journal of Urology.2018; 25(6): 524.     CrossRef
  • Cause-of-death statistics in 2016 in the Republic of Korea
    Hyun-Young Shin, Ji-Youn Lee, Jee-Eun Kim, Seokmin Lee, Heejo Youn, Heyran Kim, Jeonghun Lee, Min Sim Park, Sun Huh
    Journal of the Korean Medical Association.2018; 61(9): 573.     CrossRef
  • Is mortality-to-incidence ratio associated with health disparity in pancreatic cancer? A cross-sectional database analysis of 57 countries
    Hsiang-Lin Lee, Cheng-Ming Peng, Cheng-Yu Huang, Shin-Yi Wu, Ming-Chang Tsai, Chi-Chih Wang, Sung-Lang Chen, Chun-Che Lin, Chien-Ning Huang, Wen-Wei Sung
    BMJ Open.2018; 8(7): e020618.     CrossRef

Epidemiol Health : Epidemiology and Health
TOP